HPV Infections, Cancer of the Vulva and Therapeutical Success
NCT03082950 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2018-05-03
Summary
HPV infections may be responsible for different types of cancer in females. Primary Goal of the study was to identify the prevalence of an hpv affiliation in retrospective-prospective analysed cohort of patients who suffer from vulvar cancer and their preinvasive lesions.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
polymerase chain reaction
PCR is performed with all patients. The result (hpv positive or negative) will define the patiens Group Affiliation.
Sponsors & Collaborators
-
EUROIMMUN Medizinische Labordiagnostika AG
collaborator UNKNOWN -
University of Luebeck
lead OTHER
Principal Investigators
-
Daniel Beyer, MD · Westpfalz-Klinikum
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-05-31
Countries
- Germany
Study Locations
More Related Trials
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NCT07033091 ·Status: RECRUITING ·Phase: NA
-
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01207999 ·Status: COMPLETED
-
The Standard Management of HPV Infection
NCT03577925 ·Status: UNKNOWN
-
An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)
NCT02529930 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intraoperative HPV Testing Evaluation
NCT04190472 ·Status: UNKNOWN
-
Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota
NCT03895866 ·Status: UNKNOWN
-
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552 ·Status: TERMINATED ·Phase: NA
-
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214 ·Status: COMPLETED
-
Detecting HPV DNA in Anal and Cervical Cancers
NCT04857528 ·Status: RECRUITING
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
NCT01342978 ·Status: COMPLETED
-
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561 ·Status: RECRUITING
-
Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features
NCT03959410 ·Status: COMPLETED ·Phase: NA
-
Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities
NCT07259616 ·Status: COMPLETED
-
Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions
NCT03920800 ·Status: COMPLETED
-
Multiple Human Papillomavirus Infections in the Development of CIN
NCT06862102 ·Status: RECRUITING
-
DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
NCT00897988 ·Status: COMPLETED
-
Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases
NCT06302725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT02934724 ·Status: COMPLETED
-
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
NCT00877877 ·Status: COMPLETED ·Phase: PHASE3
-
Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
NCT06743880 ·Status: NOT_YET_RECRUITING
-
Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
NCT02323997 ·Status: COMPLETED
-
Effectiveness of Cervical Screening in HPV Vaccinated Women
NCT02149030 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
NCT06574087 ·Status: RECRUITING ·Phase: NA